Physician profile
Christopher J Van Hofwegen
NPI 1376751669
$756.38
in general payments reported to CMS, 2019-2025
11 companies · $145 in 2025
The $145 reported for 2025 was less than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $102 · 2021: $42.81 · 2022: $323 · 2023: $93.85 · 2024: $49.36 · 2025: $145.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $289.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $288.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $173.39 | 2022-2024 | Aequalis Perform Reversed |
| Si-Bone, INC. | $134.12 | 2022 | |
| Summit Surgical Corp. | $123.80 | 2019-2023 | |
| Bioventus LLC | $83.48 | 2022-2025 | Exogen Ultrasound Bone Healing System |
| Arthrex, INC. | $55.46 | 2025 | |
| Avanos Medical | $46.07 | 2022 | |
| Medical Device Business Services, INC. | $42.81 | 2021 | |
| Depuy Synthes Sales INC. | $36.99 | 2023 | Attune |
| Davol INC. | $21.92 | 2025 | |
| Becton, Dickinson and Company | $21.63 | 2025 | Channel Drain |
| Zimmer Biomet Holdings, INC. | $16.71 | 2023 | Persona |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Van Hofwegen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.